)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Spectral Medical
Spectral Medical (EDT) investor relations material
Spectral Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary7 Aug, 2026
Executive summary
Completed FDA PMA application for PMX and entered substantive review, marking a major regulatory milestone.
Positive 12-month follow-up from the Tigris trial showed sustained survival benefit for PMX.
Commercialization preparations advanced with Vantive, including platform alignment and market readiness.
Financial highlights
Q2 2026 revenue was $621,000, down 24% year-over-year due to lower reagent and service revenue.
Six-month revenue rose 9% to $1,512,000, driven by EAA Instrumentation sales.
Q2 operating expenses dropped 98% to $62,000, mainly from non-cash fair value adjustments and lower clinical costs.
Q2 net gain was $331,000 versus a $1,933,000 loss last year; six-month loss narrowed to $2,607,000 from $14,539,000.
Outlook and guidance
Focus remains on supporting FDA review, pre-approval inspections, and operational readiness for PMX launch.
Actively evaluating financing options to ensure funding beyond commercialization.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Spectral Medical
- Revenue up 56% and net loss narrowed as PMX advances toward FDA submission with new funding.EDT
Q1 2026 - PMA submission moved to Q1 2026; commercialization and financial plans remain on track.EDTStatus update
- Tigris trial showed robust 90-day mortality benefit, paving the way for FDA submission and commercialization.EDTStatus update
- Tigris trial targets full enrollment by Q1 2025, with FDA submission expected by Q3 2025.EDTStatus update
- Tigris trial fully enrolled; top-line results due August, FDA submission in October, $10M Vantive funding.EDTStatus update
- Tigris trial enrollment surged, $8.5M financing secured, and 10-year Baxter partnership extended.EDTAGM 2024
- TIGRIS enrollment, Vantive financing, and FDA submission drive momentum for 2026 launch.EDTAGM 2025
- Accelerated trial progress, revenue growth, and new funding set stage for late-2024 milestones.EDTQ2 2024
- Tigris trial nears completion amid supply chain delays; Q3 revenue up, but net loss widens.EDTQ3 2024
Next Spectral Medical earnings date
Q3 202613 Nov, 2026
Spectral Medical
Next Spectral Medical earnings date
Q3 202613 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Spectral Medical Inc is a Canadian biotechnology company focused on the development of diagnostics and therapeutics for sepsis and septic shock. The company’s product portfolio includes medical devices and biologics that aid in early detection and targeted treatment of systemic inflammatory conditions. It works with clinical partners and regulatory authorities to support commercialization efforts. The company is headquartered in Toronto, Ontario, and its shares are listed on the TSX.